Two in three adults in England are overweight or obese - and 26 per cent of us have learned all we know about treatments like ...

A pharmacist has shared three things sufferers of a 'very common' condition should do to treat themselves after it was ...

The FDA granted full approval to the menin inhibitor revumenib (Revuforj) for adults and children 1 year and older with relapsed/refractory acute leukemia and a lysine methyltransferase 2A gene ( ...

InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, today announced that the Committee for Medicinal Products for Human ...

The U.S. Food and Drug Administration has approved Bristol Myers Squibb's Cobenfy (xanomeline and trospium chloride), a first ...

It stated: “GPs issued 1.1 billion prescription items at a cost of £9.2 billion in 2015/16. The vast majority were ...

Zura Bio Limited (Nasdaq: ZURA) ("Zura Bio"), a clinical stage, multi-asset immunology company developing novel dual-pathway ...

We all know how important it is to pass stool every day, but there is too much of a good thing. Something is amiss in the ...

Cold sores, sore throats, migraines and conjunctivitis are among the conditions which will no longer be treated on the NHS by ...

BOSTON--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) today announced that Sravan Emany, Chief Operating Officer and Chief ...

The relationship between the stress response, stressors, and constipation has many layers. This article explains the physical ...